June 27, 2016 / 12:17 PM / a year ago

BRIEF-FDA accepts Spectral's expanded access protocol for toraymyxin

June 27 (Reuters) - Spectral Medical Inc

* FDA accepts spectral's expanded access protocol for toraymyxin

* Says expanded access program, sometimes referred to as compassionate use, can now begin at certain of 29 U.S. hospitals

* Says similar program is planned for Canada, where there were 12 hospitals engaged in clinical trial Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below